header
Local cover image
Local cover image
Image from OpenLibrary

Study of the possible protective effects of apigenin and plumbagin in hepatic ischemia-reperfusion injury in rats / Aya Mohamed Zaki Eid ; Supervised Hala F. Zaki , Rania M. Abdelsalam , Dalia M. Eltanbouly

By: Contributor(s): Material type: TextTextLanguage: English Publication details: Cairo : Aya Mohamed Zaki Eid , 2018Description: 168 P. : charts , photographs ; 25cmOther title:
  • دراسة التأثير الوقائى المحتمل لكل من ابيجينين و بلومباجين منفردين فى فقر الدم الموضعى و اعادة التروية فى كبد الجرذان [Added title page title]
Subject(s): Online resources: Available additional physical forms:
  • Issued also as CD
Dissertation note: Thesis (M.Sc.) - Cairo University - Faculty of Pharmacy - Department of Pharmacology and Toxicology Summary: Ischemia-reperfusion (I/R) injury is a pathological process which magnifies with the ensuing inflammatory response and endures with the increase of oxidants especially during reperfusion. The present study was conducted to assess the possible modulatory effects of two biologically active constituents of plant origin named apigenin and plumbagin, where the former is the active constituent extracted from the roots of traditional medicinal plant Plumbago zeylanica L and the latter is a flavonoid that exists abundantly in numerous herbs and vegetables, including chamomile, thyme, parsley and broccoli., on the dire role of high mobility group box (HMGB1) as well as the associated inflammation, oxidative stress and apoptotic cell death following hepatic I/R. Six groups of rats were included: sham operated, sham operated treated with apigenin, sham operated treated with plumbagin, I/R (30 min ischemia and 1 h reperfusion) , I/R treated with apigenin and I/R treated with plumbagin. Pretreatment with apigenin and plumbagin markedly improved hepatic function and histology, as indicated by reduced transaminase levels, lactate dehydrogenase activity and ameliorated tissue pathological changes. They significantly reduced high mobility group box 1 (HMGB1) expression and subsequently suppressed inflammatory cascades, as liver NF-mB and TNF-Ü as well as MPO activity. Both were capable of interrupting ROS-HMGB1loop as evident by restored liver GSH, decreased liver lipoperoxidation, and enhanced glutathione peroxidase (GPx) activity. Simultaneously, apoptosis was significantly ameliorated by increasing the Bcl-2/Bax ratio
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Home library Call number Copy number Status Barcode
Thesis Thesis قاعة الرسائل الجامعية - الدور الاول المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.08.09.M.Sc.2018.Ay.S (Browse shelf(Opens below)) Not for loan 01010110077232000
CD - Rom CD - Rom مخـــزن الرســائل الجـــامعية - البدروم المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.08.09.M.Sc.2018.Ay.S (Browse shelf(Opens below)) 77232.CD Not for loan 01020110077232000

Thesis (M.Sc.) - Cairo University - Faculty of Pharmacy - Department of Pharmacology and Toxicology

Ischemia-reperfusion (I/R) injury is a pathological process which magnifies with the ensuing inflammatory response and endures with the increase of oxidants especially during reperfusion. The present study was conducted to assess the possible modulatory effects of two biologically active constituents of plant origin named apigenin and plumbagin, where the former is the active constituent extracted from the roots of traditional medicinal plant Plumbago zeylanica L and the latter is a flavonoid that exists abundantly in numerous herbs and vegetables, including chamomile, thyme, parsley and broccoli., on the dire role of high mobility group box (HMGB1) as well as the associated inflammation, oxidative stress and apoptotic cell death following hepatic I/R. Six groups of rats were included: sham operated, sham operated treated with apigenin, sham operated treated with plumbagin, I/R (30 min ischemia and 1 h reperfusion) , I/R treated with apigenin and I/R treated with plumbagin. Pretreatment with apigenin and plumbagin markedly improved hepatic function and histology, as indicated by reduced transaminase levels, lactate dehydrogenase activity and ameliorated tissue pathological changes. They significantly reduced high mobility group box 1 (HMGB1) expression and subsequently suppressed inflammatory cascades, as liver NF-mB and TNF-Ü as well as MPO activity. Both were capable of interrupting ROS-HMGB1loop as evident by restored liver GSH, decreased liver lipoperoxidation, and enhanced glutathione peroxidase (GPx) activity. Simultaneously, apoptosis was significantly ameliorated by increasing the Bcl-2/Bax ratio

Issued also as CD

There are no comments on this title.

to post a comment.

Click on an image to view it in the image viewer

Local cover image